Grupo de investigación de biomarcadores en cáncer (GReBiC)
- Número de publicaciones
- 520
Publicaciones
-
Gion, M; Blancas, I; Cortez-Castedo, P; Cortes-Salgado, A; Marme, F; Blanch, S; Morales, S; Diaz, N; Calvo-Plaza, I; Recalde, S; Martinez-Bueno, A; Ruiz-Borrego, M; Llabres, E; Taberner, MT; de Laurentiis, M; Garcia-Vicente, S; Guerrero, JA; Boix, O; Rodriguez-Morato, J; Sampayo-Cordero, M; Antonarelli, G; Perez-Garcia, JM; Cortes, J; Llombart-Cussac, A
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
NATURE MEDICINE 31 2746-2754. .
-
Cappuyns S; Piqué-Gili M; Esteban-Fabró R; Philips G; Balaseviciute U; Pinyol R; Gris-Oliver A; Vandecaveye V; Abril-Fornaguera J; Montironi C; Bassaganyas L; Peix J; Zeitlhoefler M; Mesropian A; Huguet-Pradell J; Haber PK; Figueiredo I; Ioannou G; Gonzalez-Kozlova E; D'Alessio A; Mohr R; Meyer T; Lachenmayer A; Marquardt JU; Reeves HL; Edeline J; Finkelmeier F; Trojan J; Galle PR; Foerster F; Mínguez B; Montal R; Gnjatic S; Pinato DJ; Heikenwalder M; Verslype C; Van Cutsem E; Lambrechts D; Villanueva A; Dekervel J; Llovet JM
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma.
JOURNAL OF HEPATOLOGY 82 1036-1049. .
-
Munavvar, M; Bodtger, U; Carus, A; Cordovilla, R; Naik, S; Salud, A; Porcel, JM
Current Trends in Treating Malignant Pleural Effusion: Evidence, Guidelines, and Best Practice Recommendations
JCO Oncology Practice 21 759-765. .
-
Porcel, JM; Queimaliños, D; Alás, S; Sopena, A; Civit, C; Esquerda, A; Bielsa, S
The combination of cytospin Diff-Quik and conventional cytological examination increases the diagnostic yield for malignant pleural effusion
ERJ Open Research 11 -. .
-
Porcel, JM; Trujillano, J; Porcel, L; Esquerda, A; Bielsa, S
Development and validation of a diagnostic prediction model for heart failure-related pleural effusions: the BANCA score
ERJ Open Research 11 -. .
-
Porcel, L; Alas, S; Bielsa, S; Porcel, JM
Yield of ultrasound-guided biopsies of focal lesions in an internal medicine department
REVISTA CLINICA ESPANOLA 225 502285-502285. .
-
Rendon-Ramírez, EJ; Alvarez-Martinez, N; Solis, RC; Vaquera-Alfaro, HA; Olivo-Gutiérrez, MC; Nañez-Terreros, H; González-Aguirre, JE; Mercado-Longoria, R; Colunga-Pedraza, PR; Manjarrez-Granados, EA; González-Garza, JA; Juarez, SBM; Porcel, JM
Thoracic ultrasound in hemodialysis: Assessing fluid overload and dialysis efficacy
MEDICINE 104 -. .
-
Valladares-Ayerbes M; Toledano-Fonseca M; Graña B; Jimenez-Fonseca P; Pulido-Cortijo G; Gil S; Sastre J; Salud A; Rivera F; Salgado M; García-Alfonso P; López López R; Guillén-Ponce C; Rodríguez-Ariza A; Vieitez JM; Díaz-Rubio E; Aranda E
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer.
BMC CANCER 25 743-743. .
-
López-Fernández, A; Duran-Lozano, L; Villacampa, G; Pardo, M; Pérez, E; Darder, E; Vallmajó, A; Alfonso, R; Cruellas, M; Roqué, A; Cartró, M; Bareas, A; Carrasco, E; Rezqallah, A; Jimenez-Macedo, AR; Torres-Esquius, S; Torres, M; Lopez, C; Espinosa, M; Teulé, A; Munté, E; Tuset, N; Diez, O; Feliubadaló, L; Lázaro, C; Llort, G; Carver, T; Ficorella, L; Mavaddat, N; Mercadé, A; Antoniou, AC; Brunet, J; Cajal, TRY; Balmaña, J
A randomized study of 2 risk assessment models for individualized breast cancer risk estimation
JNCI-Journal of the National Cancer Institute 117 1593-1604. .
-
Gómez, JC; Viñas, MMC; Pérez, JMP; Bailón, MM; Martínez, PP; Marín, MTH; del Prado, N; Somoza, FJE
RECALMIN V. Evolution in the activity of internal medicine units of the National Health System (2007-2022)
REVISTA CLINICA ESPANOLA 225 211-222. .
-
Porcel, JM
The internist as an expert in invasive ultrasound: Breaking barriers
MEDICINA CLINICA 164 292-294. .
-
Rodriguez, JV; Piñol, M; Sorolla, MA; Parisi, E; Sorolla, A; Santacana, M; Ruiz, M; Parra, G; Bernabeu, M; Iglesias, M; Aracil, C; Escartin, A; Vilardell, F; Matias-Guiu, X; Salud, A; Montal, R
Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies
Journal for ImmunoTherapy of Cancer 13 -. .
